Effects on the Qt Interval of COVID-19 Coronavirus Infection

NCT04422535 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-06-09

No results posted yet for this study

Summary

The present study aims to evaluate the impact of COVID-19 disease and its treatment on ventricular repolarization, assessed by measuring the QTc interval, in patients admitted to the critical care unit.

Conditions

  • Coronavirus Infection
  • Intensive Care Patients

Sponsors & Collaborators

  • Matilde Zaballos

    lead OTHER

Principal Investigators

  • Javier Hortal, MD PhD · Hospital Universitario Gregorio Marañon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2020-09-01
Completion
2020-12-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04422535 on ClinicalTrials.gov